JW Pharmaceutical

NCT01422590

Pharmacodynamics of Mitiglinide/Sitagliptin Compared to Mitiglinide and Sitagliptin

NCT01232049

Drug Interaction and Safety Between Pitavastatin and Valsartan (CWP-PTV-101)

NCT01443221

Pharmacokinetics of Mitiglinide and Metformin in Free Combination and Fixed-dose Combination in Healthy Male Subjects.

NCT01398462

Phase I Clinical Study of CWP232291 in Acute Myeloid Leukemia Patients

NCT01406431

Pharmacokinetic Study of Livalo® Fixed Combination Drug in Healthy Subjects

NCT01764178

To Evaluate the Safety and PK Characteristics in Healthy Volunteers-Livalozet

NCT01953497

Phase 1 Study of URC102 in Healthy Subjects

NCT02524678

Phase 1 Study(Additional) of URC102 in Healthy Subjects

NCT02426723

Clinical Study of CWP232291 in Relapsed or Refractory Myeloma Patients

NCT04018170

Single and Multiple Ascending Dose Study of JW1601 for Healthy Volunteers

NCT04203836

A Trial to Evaluate the Effect of Food on LEO 152020

NCT05351840

To Evaluate the Pharmacokinetic Interactions and Safety in Healthy Volunteers

NCT05198778

A Safety, PK, PD and Food Effect Study of URC102 in Healthy Adults and Patients With Renal Impairment

NCT05463497

To Evaluate the Pharmacokinetic Drug Interactions, Safety and Drug Tolerance in Healthy Volunteers

NCT05433844

To Evaluate the PK, PD, Safety and Drug Tolerance in Healthy Volunteers

NCT05508776

A Trial to Evaluate the Effect of LEO 152020 on the Heart of Healthy People

NCT05784155

To Evaluate the PK, PD, Safety and Drug Tolerance of JW0302 in Healthy Volunteers

NCT06355349

To Evaluate the Safety and PK Characteristics in Healthy Volunteers

NCT06378684

To Evaluate the Safety and Pharmacokinetic Interactions in Healthy Volunteers

NCT06361277

To Evaluate the Pharmacokinetic Characteristics and Safety in Healthy Volunteers

NCT06435442

PK,PD and DDI of Epaminurad and Naproxen in Healthy Volunteers

NCT06816719

To Evaluate the Safety and PK Characteristics in Healthy Volunteers-JW24107

NCT06703710

To Evaluate the Safety/Tolerability and Pharmacokinetic Characteristics in Healthy Volunteers

NCT06754943

To Evaluate the Safety and PK Characteristics After Co-administration of JW0104 and C2402 and Administration of JW0105

NCT06665425

PK,PD and DDI of Epaminurad and C2406 in Healthy Volunteers

NCT07036458

To Evaluate the Mass Balance Recovery, Metabolite Profile and Metabolite Identification in Healthy Male Subjects